应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02257 圣诺医药-B
未开盘 12-19 16:08:47
3.600
+0.000
0.00%
最高
3.700
最低
3.430
成交量
25.50万
今开
3.430
昨收
3.600
日振幅
7.50%
总市值
3.79亿
流通市值
3.79亿
总股本
1.05亿
成交额
92.24万
换手率
0.24%
流通股本
1.05亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股医药板块短线拉升,来凯医药(02105.HK)涨超6%,歌礼制药(01672.HK)涨超2%,开拓药业(09939.HK)、圣诺医药(02898.
美港电讯 · 12-19 10:57
港股医药板块短线拉升,来凯医药(02105.HK)涨超6%,歌礼制药(01672.HK)涨超2%,开拓药业(09939.HK)、圣诺医药(02898.
港股生物技术板块尾盘走强,歌礼制药(01672.HK)涨超15%,圣诺医药(02257.HK)涨超9%,再鼎医药(09688.
美港电讯 · 12-18 15:31
港股生物技术板块尾盘走强,歌礼制药(01672.HK)涨超15%,圣诺医药(02257.HK)涨超9%,再鼎医药(09688.
圣诺医药-B(02257)股价上升9.687%,现价港币$3.51
阿斯达克财经 · 12-18 15:29
圣诺医药-B(02257)股价上升9.687%,现价港币$3.51
创新药概念多数上扬 圣诺医药(02257)涨11.56% 机构指医药创新是医药增长的核心动力
金吾财讯 · 12-18 09:55
创新药概念多数上扬 圣诺医药(02257)涨11.56% 机构指医药创新是医药增长的核心动力
圣诺医药-B盘中异动 早盘股价大跌8.73%报3.030港元
市场透视 · 12-17 09:43
圣诺医药-B盘中异动 早盘股价大跌8.73%报3.030港元
圣诺医药-B盘中异动 急速下挫5.35%
市场透视 · 12-16
圣诺医药-B盘中异动 急速下挫5.35%
圣诺医药(02257.HK)核数师变更
阿斯达克财经 · 12-16
圣诺医药(02257.HK)核数师变更
圣诺医药-B(02257):中汇安达获委任为新核数师
智通财经 · 12-13
圣诺医药-B(02257):中汇安达获委任为新核数师
圣诺医药-B盘中异动 快速上涨5.82%报3.090港元
市场透视 · 12-12
圣诺医药-B盘中异动 快速上涨5.82%报3.090港元
圣诺医药-B盘中异动 股价大涨5.67%报2.980港元
市场透视 · 12-11
圣诺医药-B盘中异动 股价大涨5.67%报2.980港元
圣诺医药拟12月30日召开股东特别大会审议专利转让交易
财中社 · 12-09
圣诺医药拟12月30日召开股东特别大会审议专利转让交易
圣诺医药-B盘中异动 早盘股价大涨14.81%
市场透视 · 12-09
圣诺医药-B盘中异动 早盘股价大涨14.81%
圣诺医药-B(02257):黄敏聪辞任非执行董事
智通财经 · 12-05
圣诺医药-B(02257):黄敏聪辞任非执行董事
圣诺医药-B完成发行1752.77万股股份
新浪港股 · 12-03
圣诺医药-B完成发行1752.77万股股份
圣诺医药-B(02257)完成发行1752.77万股
智通财经 · 12-02
圣诺医药-B(02257)完成发行1752.77万股
圣诺医药-B(02257):袁润廷已获委任为公司秘书
智通财经 · 12-02
圣诺医药-B(02257):袁润廷已获委任为公司秘书
圣诺医药-B(02257):盛慕娴辞任独立非执行董事
智通财经 · 11-27
圣诺医药-B(02257):盛慕娴辞任独立非执行董事
迈博药业-B盘中异动 下午盘急速下挫9.33%报0.340港元
市场透视 · 11-26
迈博药业-B盘中异动 下午盘急速下挫9.33%报0.340港元
圣诺医药-B盘中异动 早盘股价大涨8.70%报2.750港元
市场透视 · 11-26
圣诺医药-B盘中异动 早盘股价大涨8.70%报2.750港元
圣诺医药-B盘中异动 下午盘股价大跌7.14%
市场透视 · 11-22
圣诺医药-B盘中异动 下午盘股价大跌7.14%
加载更多
公司概况
公司名称:
圣诺医药-B
所属市场:
SEHK
上市日期:
--
主营业务:
Sirnaomics Ltd是一家投资控股公司。该公司及其子公司是临床阶段的生物技术公司,从事核糖核酸干扰(RNAi)技术和多种疗法的开发和商业化。该公司致力于发现和开发针对该地区未满足医疗需求的适应症的药物。其主要临床候选药物包括STP705和STP707。其STP705是一种用于治疗非黑色素瘤皮肤癌 (NMSC) 的无菌药物产品,包括原位鳞状细胞癌和基底细胞癌 (BCC)、瘢痕疙瘩切除术后复发的瘢痕疙瘩、肥厚性瘢痕 (HTS) 和实体肝肿瘤,以及 用于医学美容。其STP707是一种无菌药物产品,用于治疗实体瘤,包括肝癌、转移性皮肤鳞状细胞皮肤癌 (cSCC) 和非小细胞肺癌。其正在利用其双重交付平台,其中包括多肽纳米颗粒 (PNP) 和GalAhead。
发行价格:
--
{"stockData":{"symbol":"02257","market":"HK","secType":"STK","nameCN":"圣诺医药-B","latestPrice":3.6,"timestamp":1734595727016,"preClose":3.6,"halted":0,"volume":254950,"delay":0,"floatShares":105166176,"shares":105166176,"eps":-8.045349,"marketStatus":"未开盘","marketStatusCode":0,"change":0,"latestTime":"12-19 16:08:47","open":3.43,"high":3.7,"low":3.43,"amount":922393,"amplitude":0.075,"askPrice":3.69,"askSize":19850,"bidPrice":3.6,"bidSize":20100,"shortable":0,"etf":0,"ttmEps":-8.376642664966331,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"listingDate":1640793600000,"adjPreClose":3.6,"openAndCloseTimeList":[[1734571800000,1734580800000],[1734584400000,1734595200000]],"volumeRatio":0.532088,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02257","defaultTab":"news","newsList":[{"id":"2492919919","title":"港股医药板块短线拉升,来凯医药(02105.HK)涨超6%,歌礼制药(01672.HK)涨超2%,开拓药业(09939.HK)、圣诺医药(02898.","url":"https://stock-news.laohu8.com/highlight/detail?id=2492919919","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492919919?lang=zh_cn&edition=full","pubTime":"2024-12-19 10:57","pubTimestamp":1734577079,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1161","02898","01672","01477","02105","BK1515","BK1191","02257","09939","BK1574","159718"],"gpt_icon":0},{"id":"2492973452","title":"港股生物技术板块尾盘走强,歌礼制药(01672.HK)涨超15%,圣诺医药(02257.HK)涨超9%,再鼎医药(09688.","url":"https://stock-news.laohu8.com/highlight/detail?id=2492973452","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492973452?lang=zh_cn&edition=full","pubTime":"2024-12-18 15:31","pubTimestamp":1734507119,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1588","02257","BK1161","YANG","09688","BK4139","02197","BK1515","BK4526","BK4548","BK4588","BK1191","07226","01477","ZLAB","LU2488822045.USD","HSCEI","BK4585","BK4531","01672","HSTECH","BK1574"],"gpt_icon":0},{"id":"2492975795","title":"圣诺医药-B(02257)股价上升9.687%,现价港币$3.51","url":"https://stock-news.laohu8.com/highlight/detail?id=2492975795","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492975795?lang=zh_cn&edition=full","pubTime":"2024-12-18 15:29","pubTimestamp":1734506940,"startTime":"0","endTime":"0","summary":"[上升股]圣诺医药-B(02257) 股价在下午03:29比前收市价上升9.687%,现股价为港币$3.51。至目前为止,今日最高价为$3.82,而最低价为$3.21。总成交量为28.64万股,总成交金额为港币$101.325万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2412181396/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2492941582","title":"创新药概念多数上扬 圣诺医药(02257)涨11.56% 机构指医药创新是医药增长的核心动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2492941582","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492941582?lang=zh_cn&edition=full","pubTime":"2024-12-18 09:55","pubTimestamp":1734486946,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念多数上扬,圣诺医药 涨11.56%,百奥赛图涨9.68%,歌礼制药涨7.98%,绿竹生物涨4.73%,再鼎医药涨4.41%,康诺亚涨1.34%,中国生物制药涨0.95%,信达生物涨0.69%银河证券表示,1)医药创新是医药增长的核心动力。对于医药板块, 在“医保+商保”模式不断推进、政策支持等因素驱动下,行业规模有望进一步扩大。“医保+商保”模式打开健康险空间,创新药发展空间更大。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949850","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","159992","01672","BK1587","BK1191","BK1588","01801","159938","BK1521","01177","09939","02315","BK1583","BK1515","06978","LU2488822045.USD","09688","02162","BK1161","LU2328871848.SGD","BK1574","BK1589","02257","02480"],"gpt_icon":0},{"id":"2492068677","title":"圣诺医药-B盘中异动 早盘股价大跌8.73%报3.030港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492068677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492068677?lang=zh_cn&edition=full","pubTime":"2024-12-17 09:43","pubTimestamp":1734399815,"startTime":"0","endTime":"0","summary":"2024年12月17日早盘09时43分,圣诺医药-B股票出现异动,股价急速下跌8.73%。截至发稿,该股报3.030港元/股,成交量1200股,换手率0.00%,振幅8.73%。资金方面,该股资金流入2158港元,流出1666.5港元。圣诺医药-B股票所在的生物技术行业中,整体涨幅为0.02%。其相关个股中,晶泰控股-P、复宏汉霖、云康集团涨幅较大,振幅较大的相关个股有晶泰控股-P、圣诺医药-B、华昊中天医药-B,振幅分别为13.18%、8.73%、8.01%。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217094335a1f472d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217094335a1f472d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2491687303","title":"圣诺医药-B盘中异动 急速下挫5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491687303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491687303?lang=zh_cn&edition=full","pubTime":"2024-12-16 10:43","pubTimestamp":1734316999,"startTime":"0","endTime":"0","summary":"2024年12月16日早盘10时43分,圣诺医药-B股票出现异动,股价急速下跌5.35%。截至发稿,该股报3.360港元/股,成交量5.305万股,换手率0.05%,振幅5.35%。资金方面,该股资金流入1.6245万港元,流出16.1285万港元。圣诺医药-B股票所在的生物技术行业中,整体跌幅为0.95%。圣诺医药-B公司简介:Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216104319a1f1d3ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216104319a1f1d3ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2491819682","title":"圣诺医药(02257.HK)核数师变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2491819682","media":"阿斯达克财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491819682?lang=zh_cn&edition=full","pubTime":"2024-12-16 10:29","pubTimestamp":1734316140,"startTime":"0","endTime":"0","summary":"圣诺医药-B(02257.HK) 公布,接获德勤‧关黄陈方会计师行日期为上周五(13日)的辞任函。另外,中汇安达会计师事务所已获委任为公司核数师,同样自上周五起生效,以填补德勤辞任后的临时空缺,并任职至公司下届股东周年大会结束为止。(js/k)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220513155535487_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220513155535487_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1404252/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2491327521","title":"圣诺医药-B(02257):中汇安达获委任为新核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2491327521","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491327521?lang=zh_cn&edition=full","pubTime":"2024-12-13 21:14","pubTimestamp":1734095689,"startTime":"0","endTime":"0","summary":"智通财经APP讯,圣诺医药-B(02257)发布公告,本公司于本公告日期接获德勤‧关黄陈方会计师行(德勤)日期为2024年12月13日的辞任函。董事会进一步宣布,根据审核委员会的建议,中汇安达会计师事务所有限公司(中汇安达)已获委任为本公司核数师,自2024年12月13日起生效,以填补德勤辞任后的临时空缺并任职至本公司下届股东周年大会结束为止。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224937.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2490285338","title":"圣诺医药-B盘中异动 快速上涨5.82%报3.090港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490285338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490285338?lang=zh_cn&edition=full","pubTime":"2024-12-12 11:27","pubTimestamp":1733974028,"startTime":"0","endTime":"0","summary":"2024年12月12日早盘11时27分,圣诺医药-B股票出现波动,股价急速上涨5.82%。截至发稿,该股报3.090港元/股,成交量6.5万股,换手率0.06%,振幅5.48%。资金方面,该股资金流入8.87235万港元,流出10.5591万港元。圣诺医药-B股票所在的生物技术行业中,整体跌幅为0.29%。圣诺医药-B公司简介:Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212112708a1e7f130&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212112708a1e7f130&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2490887677","title":"圣诺医药-B盘中异动 股价大涨5.67%报2.980港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490887677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490887677?lang=zh_cn&edition=full","pubTime":"2024-12-11 15:41","pubTimestamp":1733902877,"startTime":"0","endTime":"0","summary":"2024年12月11日临近收盘15时41分,圣诺医药-B股票出现波动,股价急速上涨5.67%。截至发稿,该股报2.980港元/股,成交量2.66万股,换手率0.03%,振幅5.67%。资金方面,该股资金流入5.319万港元,流出1.28485万港元。圣诺医药-B股票所在的生物技术行业中,整体跌幅为0.89%。其相关个股中,科济药业-B、北海康成-B、思路迪医药股份涨幅较大,振幅较大的相关个股有北海康成-B、科济药业-B、思路迪医药股份,振幅分别为45.77%、37.91%、17.12%。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211154117ab6ee584&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211154117ab6ee584&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2490148795","title":"圣诺医药拟12月30日召开股东特别大会审议专利转让交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2490148795","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490148795?lang=zh_cn&edition=full","pubTime":"2024-12-09 10:46","pubTimestamp":1733712374,"startTime":"0","endTime":"0","summary":"财中社12月9日电圣诺医药-B(02257)发布公告,宣布将于2024年12月30日召开股东特别大会,主要议程包括审议专利转让及许可协议与认购安排。根据公告,专利转让及许可协议的主要条款涉及美国Sirnaomics向SagesseBio转让专利,并授予其独家、永久、可转授权的许可,以在全球范围内使用相关技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412093262716292.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2490767103","title":"圣诺医药-B盘中异动 早盘股价大涨14.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490767103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490767103?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:30","pubTimestamp":1733707859,"startTime":"0","endTime":"0","summary":"2024年12月09日早盘09时30分,圣诺医药-B股票出现波动,股价急速上涨14.81%。截至发稿,该股报3.100港元/股,成交量6.93万股,换手率0.07%,振幅0.74%。圣诺医药-B股票所在的生物技术行业中,整体涨幅为1.88%。其相关个股中,圣诺医药-B、药明康德、药明生物涨幅较大,振幅较大的相关个股有药明生物、药明康德、乐普生物-B,振幅分别为8.07%、6.50%、4.89%。圣诺医药-B公司简介:Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209093059971ca65c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209093059971ca65c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2489943198","title":"圣诺医药-B(02257):黄敏聪辞任非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2489943198","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489943198?lang=zh_cn&edition=full","pubTime":"2024-12-05 19:01","pubTimestamp":1733396473,"startTime":"0","endTime":"0","summary":"智通财经APP讯,圣诺医药-B(02257)公布,董事会接获黄敏聪先生的辞任函,由于黄敏聪先生欲投放更多时间在其他事务,故辞任非执行董事以及董事会审核委员会成员,自2025年1月1日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1220994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2488809954","title":"圣诺医药-B完成发行1752.77万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2488809954","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488809954?lang=zh_cn&edition=full","pubTime":"2024-12-03 08:52","pubTimestamp":1733187120,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 圣诺医药-B(02257)发布公告,于2024年12月2日根据2024年10月2日的认购协议,完成根据一般授权认购新股份后发行股份1752.77万股。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-03/doc-incyctzv1884642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2488627976","title":"圣诺医药-B(02257)完成发行1752.77万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488627976","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488627976?lang=zh_cn&edition=full","pubTime":"2024-12-02 19:10","pubTimestamp":1733137853,"startTime":"0","endTime":"0","summary":"智通财经APP讯,圣诺医药-B(02257)发布公告,于2024年12月2日根据2024年10月2日的认购协议,完成根据一般授权认购新股份后发行股份1752.77万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1219188.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2488692007","title":"圣诺医药-B(02257):袁润廷已获委任为公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2488692007","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488692007?lang=zh_cn&edition=full","pubTime":"2024-12-02 06:40","pubTimestamp":1733092812,"startTime":"0","endTime":"0","summary":"智通财经APP讯,圣诺医药-B(02257)发布公告,梁庭彰已辞任公司秘书、香港联合交易所有限公司证券上市规则第3.05条项下的公司授权代表,以及根据香港法例第622章公司条例第16部在香港代表公司接受送达法律程序文件或通知书的授权代表,自2024年11月30日起生效。袁润廷已获委任为公司秘书、授权代表及法律程序文件代理人以取替梁先生,自2024年11月30日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1218657.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2486844799","title":"圣诺医药-B(02257):盛慕娴辞任独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2486844799","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486844799?lang=zh_cn&edition=full","pubTime":"2024-11-27 19:02","pubTimestamp":1732705335,"startTime":"0","endTime":"0","summary":"智通财经APP讯,圣诺医药-B(02257)发布公告,该公司董事会接获盛慕娴的辞任函,由于盛慕娴欲投放更多时间在其他事务,故辞任独立非执行董事、董事会审核委员会主席兼成员以及董事会提名委员会成员,自2025年1月1日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1216790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2486502801","title":"迈博药业-B盘中异动 下午盘急速下挫9.33%报0.340港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486502801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486502801?lang=zh_cn&edition=full","pubTime":"2024-11-26 15:16","pubTimestamp":1732605366,"startTime":"0","endTime":"0","summary":"2024年11月26日下午盘15时16分,迈博药业-B股票出现波动,股价急速下挫9.33%。截至发稿,该股报0.340港元/股,成交量4万股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出1.36万港元。迈博药业-B股票所在的生物技术行业中,整体涨幅为0.07%。迈博药业-B公司简介:迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126151606abdfd944&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126151606abdfd944&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","02181","BK1161","BK1574","02257"],"gpt_icon":0},{"id":"2486097655","title":"圣诺医药-B盘中异动 早盘股价大涨8.70%报2.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486097655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486097655?lang=zh_cn&edition=full","pubTime":"2024-11-26 10:09","pubTimestamp":1732586972,"startTime":"0","endTime":"0","summary":"2024年11月26日早盘10时09分,圣诺医药-B股票出现异动,股价大幅拉升8.70%。截至发稿,该股报2.750港元/股,成交量50股,换手率0.00%,振幅0.00%。资金方面,该股资金流入137.5港元,流出0港元。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。圣诺医药-B股票所在的生物技术行业中,整体涨幅为0.26%。圣诺医药-B公司简介:Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126100932971a8827&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126100932971a8827&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2485628948","title":"圣诺医药-B盘中异动 下午盘股价大跌7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485628948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485628948?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:50","pubTimestamp":1732258239,"startTime":"0","endTime":"0","summary":"2024年11月22日下午盘14时50分,圣诺医药-B股票出现异动,股价大幅下挫7.14%。资金方面,该股资金流入1.627万港元,流出13.217万港元。圣诺医药-B股票所在的生物技术行业中,整体跌幅为1.40%。其相关个股中,迈博药业-B、云康集团、来凯医药-B涨幅较大,振幅较大的相关个股有华领医药-B、晶泰科技、云康集团,振幅分别为16.67%、15.10%、14.00%。圣诺医药-B公司简介:Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112214503998e441b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112214503998e441b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0}],"profile":{"websiteUrl":"https://www.sirnaomics.com/en/","stockEarnings":[{"period":"1week","weight":0.1392},{"period":"1month","weight":0.3284},{"period":"3month","weight":0.1392},{"period":"6month","weight":-0.3309},{"period":"1year","weight":-0.9045},{"period":"ytd","weight":-0.8994}],"compareEarnings":[{"period":"1week","weight":-0.0316},{"period":"1month","weight":0.0045},{"period":"3month","weight":0.0818},{"period":"6month","weight":0.0956},{"period":"1year","weight":0.1889},{"period":"ytd","weight":0.1587}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Sirnaomics Ltd是一家投资控股公司。该公司及其子公司是临床阶段的生物技术公司,从事核糖核酸干扰(RNAi)技术和多种疗法的开发和商业化。该公司致力于发现和开发针对该地区未满足医疗需求的适应症的药物。其主要临床候选药物包括STP705和STP707。其STP705是一种用于治疗非黑色素瘤皮肤癌 (NMSC) 的无菌药物产品,包括原位鳞状细胞癌和基底细胞癌 (BCC)、瘢痕疙瘩切除术后复发的瘢痕疙瘩、肥厚性瘢痕 (HTS) 和实体肝肿瘤,以及 用于医学美容。其STP707是一种无菌药物产品,用于治疗实体瘤,包括肝癌、转移性皮肤鳞状细胞皮肤癌 (cSCC) 和非小细胞肺癌。其正在利用其双重交付平台,其中包括多肽纳米颗粒 (PNP) 和GalAhead。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.167511},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.03691},{"month":3,"riseRate":0,"avgChangeRate":-0.172651},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.052148},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.043175},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.070836},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.031654},{"month":8,"riseRate":0,"avgChangeRate":-0.174046},{"month":9,"riseRate":0.666667,"avgChangeRate":0.106213},{"month":10,"riseRate":0,"avgChangeRate":-0.124587},{"month":11,"riseRate":0,"avgChangeRate":-0.053191},{"month":12,"riseRate":0.666667,"avgChangeRate":0.049038}],"exchange":"SEHK","name":"圣诺医药-B","nameEN":"SIRNAOMICS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣诺医药-B(02257)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣诺医药-B(02257)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣诺医药-B,02257,圣诺医药-B股票,圣诺医药-B股票老虎,圣诺医药-B股票老虎国际,圣诺医药-B行情,圣诺医药-B股票行情,圣诺医药-B股价,圣诺医药-B股市,圣诺医药-B股票价格,圣诺医药-B股票交易,圣诺医药-B股票购买,圣诺医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣诺医药-B(02257)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣诺医药-B(02257)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}